September 10, 2019, the U.S. Federal Trade Commission (“FTC”) issued a news release announcing the recent distribution of warning letters to three companies advertising cannabidiol (“CBD”) products as a medical treatment option for a range of various illnesses. Cautioning that such unsubstantiated … Read more about Recent FTC Warning Letters Target CBD Medical Claims
California Poised to Permit Sale of CBD-Infused Products
Through a bill proposed earlier this year, California legislators appear to be on the verge of legalizing the sale of food, drink, and cosmetic products containing hemp or associated cannabinoids, such as cannabidiol (“CBD”). Per last year’s announcement from the California Department of Public … Read more about California Poised to Permit Sale of CBD-Infused Products
New Data Projects Decrease in CBD Prices
Cannabidiol (“CBD”) products have garnered unprecedented levels of market interest following the Agriculture Improvement Act of 2018 (“2018 Farm Bill”). Indeed, even though the Food and Drug Administration (“FDA”) still considers ingestible CBD consumer products to be prohibited – the drug Epidiolex … Read more about New Data Projects Decrease in CBD Prices
Firm Attends FDA Hearing on Cannabis and Derived Products
Last Friday, May 31, the U.S. Food and Drug Administration (“FDA”) held their first public hearing regarding cannabis and cannabis-derived products. Influenced by the recent market boom of hemp and cannabidiol (“CBD”) products, the FDA’s hearing presented an opportunity for industry … Read more about Firm Attends FDA Hearing on Cannabis and Derived Products
Founder and Managing Partner Selected to Testify at FDA Public Hearing
It is with great pride that we announce that our Founder and Managing Partner, Dave Rodman has been selected by the U.S. Food and Drug Administration (“FDA”) to give oral testimony regarding the safety of products containing cannabis-derived compounds, specifically cannabidiol (“CBD”), at the … Read more about Founder and Managing Partner Selected to Testify at FDA Public Hearing
TTB Rejects Use of CBD in Alcohol Beverages
The U.S. Alcohol and Tobacco Tax and Trade Bureau ("TTB") has joined the discussion regarding the legality of hemp and hemp-derived additives in consumable items. In a bureau-wide bulletin, the agency addressed wineries, distilleries, breweries, and importers hoping to add ingredients like … Read more about TTB Rejects Use of CBD in Alcohol Beverages
Vitamin Shoppe Enters Consumable CBD Market
Earlier this week, nutritional supplement retail chain Vitamin Shoppe announced that the company has started to offer cannabidiol (“CBD”) soft gels to eligible customers. Limited to 14 states, Washington, D.C., and Puerto Rico, Vitamin Shoppe began selling Irwin Naturals’ CBD soft gels earlier this … Read more about Vitamin Shoppe Enters Consumable CBD Market
Carl’s Jr. To Release CBD-Infused Cheeseburger
This week, for one time only, fast-food chain Carl’s Jr. will be selling the first cannabidiol (“CBD”) infused cheeseburger. On Saturday, April 20, the chain will offer the "Rocky Mountain High Cheese Burger Delight" CBD burger at one location in Denver, priced at $4.20. The burger contains of two … Read more about Carl’s Jr. To Release CBD-Infused Cheeseburger